XML 70 R40.htm IDEA: XBRL DOCUMENT v2.4.1.9
Derivative Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2014
Derivative Instrument Detail [Abstract]  
Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]
The following table summarizes the terms of the Company's outstanding interest rate swap agreements entered into to manage the Company's exposure to changes in interest rates on its variable rate debt (dollars in thousands):

 
 
 
Notional Amount
 
 
 
 
Effective Date
 
Expiration Date
 
Date
 
Amount
 
Pay Fixed Rate
 
Receive Variable Rate
9/30/2014
 
9/30/2015
 
9/30/2014
 
$
1,150,000

 
0.54%
 
1-month LIBOR
 
 
 
 
12/31/2014
 
$
1,100,000

 
0.54%
 
1-month LIBOR
 
 
 
 
3/31/2015
 
$
1,050,000

 
0.54%
 
1-month LIBOR
 
 
 
 
6/30/2015
 
$
1,000,000

 
0.54%
 
1-month LIBOR
9/30/2015
 
9/30/2016
 
9/30/2015
 
$
350,000

 
0.93%
 
1-month LIBOR
9/30/2016
 
9/30/2026
 
9/30/2026
 
$
100,000

 
2.79%
 
3-month LIBOR
9/30/2016
 
9/30/2026
 
9/30/2026
 
$
100,000

 
2.79%
 
3-month LIBOR
9/30/2016
 
9/30/2026
 
9/30/2026
 
$
100,000

 
2.80%
 
3-month LIBOR
Schedule of Notional Amounts of Expired Derivative [Table Text Block]
The following table summarizes the Company's interest rate swap agreements that expired during 2014 and 2013 (dollars in thousands):
 
 
 
 
Notional Amount
 
 
 
 
Effective Date
 
Expiration Date
 
Date
 
Amount
 
Paid Fixed Rate
 
Receive Variable Rate
10/6/2008
 
9/30/2013
 
10/6/2008
 
$
120,000

 
3.88%
 
1-month LIBOR
10/4/2012
 
9/30/2013
 
10/4/2012
 
$
1,450,000

 
0.25%
 
1-month LIBOR
 
 
 
 
1/1/2013
 
$
1,350,000

 
0.25%
 
1-month LIBOR
 
 
 
 
4/1/2013
 
$
1,300,000

 
0.25%
 
1-month LIBOR
 
 
 
 
7/1/2013
 
$
1,250,000

 
0.25%
 
1-month LIBOR
9/30/2013
 
9/30/2014
 
9/30/2013
 
$
1,350,000

 
0.35%
 
1-month LIBOR
 
 
 
 
12/31/2013
 
$
1,300,000

 
0.35%
 
1-month LIBOR
 
 
 
 
3/31/2014
 
$
1,250,000

 
0.35%
 
1-month LIBOR
 
 
 
 
6/30/2014
 
$
1,200,000

 
0.35%
 
1-month LIBOR
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]
The following table summarizes the fair value of the Company's derivative instruments recorded in the consolidated balance sheets as of December 31, 2014 and 2013 (dollars in thousands): 
 
 
 
 
Fair Value
 
 
Balance Sheet Location
 
2014
 
2013
Asset Derivatives:
 
 
 
 
 
 
Derivatives designated as hedges:
 
 
 
 
 
 
Interest rate swap agreements
 
Prepaid expenses and other
 
$
35

 
$

Interest rate swap agreements
 
Other assets, net
 
101

 
36,987

Total derivatives designated as hedges
 
 
 
$
136

 
$
36,987

Derivatives not designated as hedges:
 
 
 
 
 
 
Cross-currency swap agreements
 
Prepaid expenses and other
 
$

 
$
16,056

Liability Derivatives:
 
 
 
 
 
 
Derivatives designated as hedges:
 
 
 
 
 
 
Interest rate swap agreements
 
Accrued expenses
 
$
2,249

 
$
1,601

Interest rate swap agreements
 
Other long-term liabilities
 
2,462

 
838

Total derivatives designated as hedges
 
 
 
$
4,711

 
$
2,439

Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]
The following table shows the effect of the Company's derivative instruments designated as cash flow hedges for the years ended December 31, 2014, 2013 and 2012 in other comprehensive income/(loss) (OCI) (dollars in thousands): 
 
 
Total Cash Flow
Hedge OCI Activity,
Net of Tax
 
 
2014
 
2013
 
2012
Derivatives Designated as Cash Flow Hedges:
 
 
 
 
 
 
Effective portion of changes in fair value recognized in OCI:
 
 
 
 
 
 
Interest rate swap agreement
 
$
(23,473
)
 
$
20,988

 
$
4,053

Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]
The following table shows the effect of the Company's derivative instruments not designated as hedges for the years ended December 31, 2014, 2013 and 2012 in the consolidated statements of operations (dollars in thousands): 
 
 
 
Amount Recognized in Earnings
 
Location of Amount Recognized
in Earnings
 
2014
 
2013
 
2012
Derivative Instruments Not Designated as Hedges:
 
 
 
 
 
 
 
Cross-currency swap agreements
Interest (expense)/income
 
$
(1,184
)
 
$
(2,696
)
 
$
(4,638
)
Cross-currency swap agreements
Other (expense)/income, net
 
(86
)
 
427

 
303

Contingent forward sale contract
Contingent forward sale contract mark-to-market expense
 

 

 
(50,106
)
 
 
 
$
(1,270
)
 
$
(2,269
)
 
$
(54,441
)